Durvalumab Post Concurrent Chemoradiotherapy in Japanese Patients With Limited-Stage Small-Cell Lung Cancer in the Phase 3 ADRIATIC Trial
Cancer Sci. 2025 Sep 21. doi: 10.1111/cas.70188. Online ahead of print. ABSTRACT At the first interim analysis of the global, […]

